CircRNA expression profile and functional analysis in retinal ischemia-reperfusion injury.

Genomics

Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, China; Shanghai Key Laboratory of Visual Impairment and Rest

Published: May 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Retinal ischemia-reperfusion (I/R) is involved in the pathogenesis of many vision-threatening diseases. circRNAs act as key players in gene regulation and human diseases. However, the global circRNA expression profile in retinal I/R injury has not been fully uncovered. Herein, we established a murine model of retinal I/R injury and performed circRNA microarrays to identify I/R-related circRNAs. 1265 differentially expressed circRNAs were identified between I/R retinas and normal retinas. Notably, the detection of cWDR37 level in aqueous humor could discriminate glaucoma patients from cataract patients (AUC = 0.9367). cWdr37 silencing protected against hypoxic stress- or oxidative stress-induced retinal ganglion cell (RGC) injury. cWdr37 silencing alleviated IR-induced retinal neurodegeneration as shown by increased NeuN staining, reduced retinal reactive gliosis, and decreased retinal apoptosis. Collectively, this study provides a novel insight into the pathogenesis of retinal I/R injury. cWdr37 is a promising target for the diagnosis or treatment of I/R-related ocular diseases.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygeno.2021.03.026DOI Listing

Publication Analysis

Top Keywords

retinal i/r
12
i/r injury
12
retinal
9
circrna expression
8
expression profile
8
retinal ischemia-reperfusion
8
cwdr37 silencing
8
injury cwdr37
8
injury
5
i/r
5

Similar Publications

Plasma rich in growth factors as a treatment for ocular fundus diseases: Mapping current applications and future directions.

Biomed Pharmacother

August 2025

University Institute for Regenerative Medicine and Oral Implantology - UIRMI (UPV/EHU-Fundación Eduardo Anitua), Vitoria 01007, Spain; BTI Biotechnology Institute, Vitoria, Spain; Adjunct Assistant Professor, Faculty of Dentistry, University of Jordan, Amman 11942, Jordan.

Posterior segment diseases are a leading cause of irreversible blindness and remain challenging to treat with current therapies. Blood-derived products have emerged as promising regenerative tools due to their anti-inflammatory, neuroprotective, and regenerative properties. This review synthesizes evidence from 46 clinical studies published between 2019 and 2025, covering 1253 patients and 1570 eyes treated with platelet-rich derivatives for ocular fundus diseases.

View Article and Find Full Text PDF

Background: Glaucoma is a leading cause of blindness characterized by retinal ganglion cell (RGC) degeneration. SA-10, a dual-acting compound with ROS scavenging and NO-donating properties, was evaluated to enhance RGC survival and function in models of oxidative stress, ischemia/reperfusion (I/R) injury, and neurotrophic factor (NF) deprivation.

Methods: SA-10-loaded nanoparticles (SA-10-NP) with a size of 279.

View Article and Find Full Text PDF

NeuN expression in health and disease: A histological perspective on neuronal heterogeneity.

Histol Histopathol

July 2025

Department of Emergency Medicine, School of Medicine, Kangwon National University, Chuncheon, Republic of Korea.

Neuronal nuclei (NeuN), also known as Rbfox3, is a widely used neuronal marker for identifying postmitotic neurons in both basic neuroscience and diagnostic neuropathology. Since its discovery, NeuN immunoreactivity has enabled accurate neuron counting, injury assessment, and anatomical mapping. However, accumulating evidence demonstrates that NeuN is not universally expressed across all mature neurons.

View Article and Find Full Text PDF

The purpose of this study was to assess the retinal relative peripheral refraction (RPR) in children with low myopia and pre-myopia, and investigate the differences in RPR using multispectral refraction topography (MRT). Ninety-five children were enrolled in the Department of Ophthalmology, Jinshan Hospital affiliated to Fudan University. MRT could measure total RPR (TRPR) of the 53° range centered on macular fovea.

View Article and Find Full Text PDF

Integrated single-cell RNA and ATAC sequencing of B-cell lymphoma-3(Bcl3) and endothelin-2(Edn2) proteins as targets to prevent glaucoma progression.

Int J Biol Macromol

August 2025

Department of Ophthalmology, Chongqing Key Laboratory for the Prevention and Treatment of Major Blinding Eye Diseases, Chongqing Eye Institute, Chongqing Branch of National Clinical Research Center for Ocular Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Background: Glaucoma is the leading cause of irreversible vision impairment worldwide. However, the mechanisms underlying primary open-angle glaucoma (POAG), the most common form of glaucoma, are not yet fully understood.

Methods: Single-cell RNA sequencing (scRNA-seq), bulk RNA sequencing, and ATAC-seq datasets (GSE203499, GSE212186, GSE241782, GSE212188) containing data from glaucoma and control samples were analyzed to identify differentially expressed genes (DEGs) and chromatin accessibility changes.

View Article and Find Full Text PDF